Lynne Bui is an Oncology physician. OpenAlex indexes 27 publications with 971 citations (h-index 13); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9460 N Name Uno Ste 230
Gilroy, CA 950203538
Telephone
408-384-9284Provider last certified this registry record 3 Aug 2022.
Clinical trials
- Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer
Sponsor: Symphony Evolution, Inc.
- Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
Sponsor: Symphony Evolution, Inc.
- Study of XL999 in Patients With Multiple Myeloma
Sponsor: Symphony Evolution, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
56 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202512 payments
- GlaxoSmithKline, LLC.Program year20253 payments
- Dompe US, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2022–2022 per NIH RePORTER. The latest:
- Human Disease-Specific Induced Pluripotent Stem Cells For Preclinical Drug Testing and Drug Discovery
Khloris Biosciences, Inc.
FY2022$1,728,439R44HL158281
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 414 Efficacy and immunogenicity of induced pluripotent stem cell (iPSC) vaccine is independent of iPSC viability in a prophylactic mouse model of breast cancer
Regular and Young Investigator Award Abstracts
2023 - 415 Both allogeneic and syngeneic induced pluripotent stem cell (iPSC) vaccines decrease tumor growth and improve survival in a prophylactic mouse model of breast cancer
Regular and Young Investigator Award Abstracts
2023 - 775 An induced pluripotent stem cell (iPSC) vaccine decreases tumor growth and improves survival in a therapeutic mouse model of colon cancer
Regular and Young Investigator Award Abstracts
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”